HU Ziteng,LIANG Ning,YAN Lijiao,et al.Methodology for the Development of Clinical Practice Guidelines for Chinese Patent Medicine(Part 3): Identification of Clinical Questions[J].Journal of Traditional Chinese Medicine,2024,65(01):55-59.
HU Ziteng,LIANG Ning,YAN Lijiao,et al.Methodology for the Development of Clinical Practice Guidelines for Chinese Patent Medicine(Part 3): Identification of Clinical Questions[J].Journal of Traditional Chinese Medicine,2024,65(01):55-59.DOI: 10.13288/j.11-2166/r.2024.01.011.
Methodology for the Development of Clinical Practice Guidelines for Chinese Patent Medicine(Part 3): Identification of Clinical Questions
The identification of clinical questions for clinical practice guidelines of Chinese patent medicine (CPM) is important for subsequent evidence retrieval, evaluation of evidence quality, formation of recommendations. This paper described a methodological proposal for the identification of clinical questions for CPM guidelines to highlight the characteristics of Chinese patent medicine and reflect its effect in specific stage of the disease. Considering four aspects, namely, the drug of Chinese patent medicine (D), the specific disease stage (S), comparison (C), and specific outcome (O), DSCO framework has been proposed to formulate the clinical questions. Multi-source information through scientific research, policy or standard documents, and clinical data are suggested for collecting clinical questions, and clear selection criteria should be set to finalize the clinical questions to be addressed by the guideline. In addition, the above process needs to be transparently and publicly reported in order to ensure the clarity and completeness of the guidelines.
National Institute for Health and Care Excellence . Deve-loping NICE guidelines: the manual [EB/OL].( 2014-10-31 )[ 2023-08-02 ]. https://www.nice.org. uk/process/pmg20/resources/developing-nice-guidelines-the-manual-pdf-72286708700869 https://www.nice.org.uk/process/pmg20/resources/developing-nice-guidelines-the-manual-pdf-72286708700869 .
World Health Organization . WHO handbook for guideline development [M]. 2nd ed . Geneva : WHO Library , 2014 : 79 .
British Thoracic Society . British Thoracic Society standards of care committee guideline production manual [EB/OL].( 2013-07-01 )[ 2023-08-02 ]. https://www.brit-thoracic.org.uk/media/455938/bts-guideline-production- manual-2022.pdf https://www.brit-thoracic.org.uk/media/455938/bts-guideline-production-manual-2022.pdf .
Disease Kidney : Improving Global Outcomes . KDIGO announces release of methods manual for guideline deve-lopment [EB/OL].( 2022-12-21 )[ 2023-08-02 ]. https://kdigo.org/wp-content/uploads/2022/12/KDIGO-Methods-Manual-for-Guideline-Development_v1-3-copy-1.pdf https://kdigo.org/wp-content/uploads/2022/12/KDIGO-Methods-Manual-for-Guideline-Development_v1-3-copy-1.pdf .
NAGLER EV , WEBSTER AC , BOLIGNANO D , et al . European Renal Best Practice (ERBP) guideline development methodology: towards the best possible guidelines [J]. Nephrol Dial Transplant , 2014 , 29 ( 4 ): 731 - 738 .
American College of Obstetricians and Gynecologists' Evidence-Based Medicine Expert Work Group . Clinical practice guideline methodology [J]. Obstet Gynecol , 2021 , 138 ( 3 ): 518 - 522 .
BROUWERS MC , KERKVLIET K , SPITHOFF K , et al . The AGREE reporting checklist: a tool to improve reporting of clinical practice guidelines [J]. BMJ (Clinical research ed) , 2016 , 352 : i1152 . doi: 10.1136/bmj.i4852 http://dx.doi.org/10.1136/bmj.i4852 .
CHEN Y , YANG K , MARUŠIC A , et al . A reporting tool for practice guidelines in health care: the RIGHT statement [J]. Ann Intern Med , 2017 , 166 ( 2 ): 128 - 132 .
SHIFFMAN RN , SHEKELLE P , OVERHAGE JM , et al . Standardized reporting of clinical practice guidelines: a proposal from the conference on guideline standardization [J]. Ann Intern Med , 2003 , 139 ( 6 ): 493 - 498 .
Methodology for the Development of Clinical Practice Guidelines for Chinese Patent Medicine(Part 5): Retrieval and Synthesis of Key Information on Rational Drug Use
Methodology for the Development of Clinical Practice Guidelines for Chinese Patent Medicine(Part 4): Evidence Retrieval and Evaluation
The Difficulties and Methodological Suggestions for the Recommendation Formation of Clinical Practice Guidelines of Traditional Chinese Medicine
Methodology for the Development of Clinical Practice Guidelines for Chinese Patent Medicine (Part 6): Formation and Presentation of Recommendations
Methodology for the Development of Clinical Practice Guidelines for Chinese Patent Medicine (Part 7): Introduction and Interpretation of the Guideline Reporting Checklist
Related Author
LIU Bin
CHE Qianzi
LI Yixiang
GUO Jing
ZONG Xingyu
WANG Weili
LI He
GAO Yicheng
Related Institution
Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine/Institute for Excellence in Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine
Center for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine
School of Traditional Chinese Medicine,Beijing University of Chinese Medicine
Japan Friendship Hospital
Lung Disease Diagnosis and Treatment,The First Affiliated Hospital of Henan University of Chinese Medicine